Rational Modifications of HIV-1 Envelope Glycoproteins for Immunogen Design

E-ISSN： 1873-4286|13|2|213-227

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.13, Iss.2, 2007-01, pp. : 213-227

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Potential Drug Targets on the HIV-1 Envelope Glycoproteins, gp120 and gp41

Current Pharmaceutical Design, Vol. 9, Iss. 18, 2003-07 ,pp. : 1453-1462

Bentham Science Publishers

Access to resources Recommend Favorite

HIV-1 immunogen does not appear to improve HIV progression-free survival

Inpharma, Vol. 1, Iss. 1263, 2000-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Biochemistry and Biophysics of HIV-1 gp41 - Membrane Interactions and Implications for HIV-1 Envelope Protein Mediated Viral-Cell Fusion and Fusion Inhibitor Design

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 24, 2011-12 ,pp. : 2959-2984

Bentham Science Publishers

Access to resources Recommend Favorite

Glycosylation of HIV-1 gp120 V3 Loop: Towards the Rational Design of a Synthetic Carbohydrate Vaccine

Current Medicinal Chemistry, Vol. 14, Iss. 30, 2007-12 ,pp. : 3232-3242

Bentham Science Publishers

Access to resources Recommend Favorite

HIV-1 Envelope Evolution and Vaccine Efficacy

Current Drug Targets - Infectious Disorders, Vol. 5, Iss. 2, 2005-06 ,pp. : 171-177

Bentham Science Publishers

Access to resources Recommend Favorite